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ABSTRACT
We focus on the new problem of determining which methylation patterns
in gene promoters strongly associate with gene expression in cancer cells
of different types. Although a number of results regarding the influence of
methylation on expression data have been reported in the literature, our
approach is unique insofar as it retrospectively predicts the combinations of
methylated sites in promoter regions of genes that are reflected in the expres-
sion data. Reversing the traditional prediction order in many cases makes
estimation of the model parameters easier, as real-valued data are used to
predict categorical data, rather than vice-versa; in addition, our approach
allows one to better assess the overall influence of methylation in modulating
expression via state-of-the-art learning methods. For this purpose, we devel-
oped a novel neural network learning framework termed E2M (Expression-to-
Methylation) to predict the status of different methylation sites in promoter
regions of several bio-marker genes based on sufficient statistics of the whole
gene expression captured through Landmark genes. We ran our experiments
on unquantized and quantized expression sets and neural network weights to
illustrate the robustness of the method and reduce the storage footprint of
the processing pipeline.
We implemented a number of machine learning algorithms to address the
new problem of methylation pattern inference, including multiclass regres-
sion, canonical correlation analysis (CCA), naive fully connected neural net-
work and inception neural networks. Inception neural networks such as
E2M learners outperform all other techniques and offer an average predic-
tion accuracy of 82% when tested on 3, 671 pan-cancer samples including low
grade glioma, glioblastoma, lung adenocarcinoma, lung squamus cell carci-
noma, and stomach adenocarcinoma. As an illustrative example, one can
increase the prediction accuracy for the methylation pattern in the promoter
of gene GATA6 in glioblastoma samples by 20% when using inception rather
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than simple fully connected neural networks. These performance guarantees
remain largely unchanged even when both expression values and network
weights are quantized. Our work also provides new insight about the impor-
tance of specific methylation site patterns on expression variations for differ-
ent genes. In this context, we identified genes for which the overwhelming
majority of patients exhibit one methylation pattern, and other genes with
three or more significant classes of methylation patterns. Inception networks
identify such patterns with high accuracy and suggest possible stratification
of cancers based on methylation pattern profiles.
The E2M code and datasets are freely available at https://github.com/
jianhao2016/E2M
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Recent studies in computational biology have focused on analyzing multi-
omics datasets in order to gain a better understanding of the relationships
between different dataset components and their unique information content,
and to elucidate the relationships between their underlying biological phe-
nomena. This is of particular importance for the case of gene expression data,
as there are many genomic and epigenomic factors that influence gene expres-
sion (e.g., transcriptional regulation, methylation and histone modification,
copy number variation, etc) and as gene expression itself affects almost all
aspects of cellular function [1, 2, 3, 4, 5]. One approach to determine to which
extent gene expression is determined by or determines other molecular and
biochemical modularities is to predict expression values based on associated
datasets, such as methylation data [6, 7, 8]. For this task, many learning
methods are available, such as logistic regression and deep learning [9, 10].
If the prediction accuracy of the expression values is high, it is reasonable
to assume that corresponding data are statistically correlated and that the
processes under consideration are biologically interlinked.
Several lines of work in this areas have focused on applying machine learn-
ing methods on gene expression data in order to predict clinical outcomes
or the dynamics of diseases. In [11], the authors identified a subset of genes
whose expression values have strong diagnostic value in cancer staging and
survival rate evaluation. The work described in [12] focused on predicting
gene expression values based on histone modification data, while taking into
account the inherent redundancy present in combined gene expression pro-
files.
Of particular interest are analyses involving expression and methylation
datasets, as methylation is known to be one of the key regulators of expres-
sion [13] (see Figure 1.1). Methylation is a common epigenetic modification
[14] that plays an important role in tumorigenesis and cancer progression.
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The methylation process alters the chemical structure of cytosine or guanine
at CpG sites, which often cluster within CpG islands in promoter regions of
genes. Although a CpG island may contain tens of CpG sites, it has been
a standard practice to only report the thresholded cumulative methylation
effect of the sites and declare a binary methylation state of a gene (methy-
lated or unmethylated). In order to associate DNA methylation with gene
expression changes, the authors of [8] proposed a supervised learning method
termed ME-Class (Methylation-based Expression Classification) for predict-
ing expression changes based on soft methylation features. The goal of the
aforementioned study was to assess the raw predictive power of methyla-
tion data, rather than to determine which combinations of methylation sites
truly contribute to the observed expression profiles. On the other hand, the
authors of [15] proposed an attention model which utilized both the expres-
sion data and CpG sites distance information to predict methylation states
of one CpG site. Our work hence centers on a higher-order and in-depth
analysis of the mutual relationship between expression and methylation site
patterns in the context of pan cancer data analysis. The natural approach
to pursue within this framework is retrospective analysis, which amounts to
inferring methylation patterns (i.e., discrete states) from expression values
(i.e., continuous observations).
Our technical contributions are three-fold. First, we introduce the problem
of correlating binary methylation patterns with the expressions of Landmark
genes [16]. This significantly reduces the complexity of the problem and
simultaneously performs denoising of expression values, as the set of Land-
mark genes is rather small (≈ 1000) and selected for its predictive power
for whole-genome expressions. Second, we propose a new inception network
[17] architecture for deep learning, termed E2M, which performs retrospec-
tive classification. The prediction accuracy of the E2M network is up to 20%
better than that offered by traditional multi-class logistics regression and
three-layer fully connected networks. Third, we demonstrate that our learn-
ing framework can operate with quantized parameter sets and significantly
compressed datasets. Large-depth neural networks are known to be more ro-
bust to noise [18, 19] than shallow networks, but their practical application
is limited by their large storage footprint. To show that this problem may
be easily mitigated via quantization, we demonstrate that 8-bit uniformly
quantized expression values and 16-bit quantized network weights cause neg-
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ligible degradations in recovering underlying methylation patterns for almost
all tested examples.
Our analysis also reveals that methylation patterns are gene-dependent
and that they influence the expression dynamics differently for different types
of cancers. In some cases, such as lung cancer, the methylation patterns in
genes such as MGMT, ATM, GATA6 and KRAS differ significantly, while the
methylation patterns in the MLH1 and CASP8 genes show little variation.
For some other cases, such as brain cancer, most genes show very similar
methylation patterns, except for GATA6. Furthermore, some genes, such as
TP53, have a unique methylation pattern for a specific cancer type, and the
patterns vary little across cancer types.
Figure 1.1: Associations between gene expression and DNA methylation




We start our exposition by describing the datasets used in our analysis, and
then proceed with a discussion of existing and new methods suitable for
addressing the prediction problem at hand.
2.1 Data Description
The problem of associating different types of multiomics data has received
significant attention in the computational biology community [20, 21]. To
assess the performance of the proposed framework E2M, we restrict our at-
tention to human cancer cell expression and methylation data. Our goal is
to predict methylation patterns from gene expression values.
There are over 20, 000 genes in the human genome, and using their gene
expression values directly in any machine learning task would lead to un-
determined problems and overfitting issues due to redundancy and small
sample set sizes. Hence, the first step in our approach is to perform dimen-
sionality reduction. To this end, we focus on expression levels of so-called
L1000 Landmark genes, comprising 978 genes. This subset of genes has been
carefully selected by the NIH LINCS project (http://lincsportal.ccs.
miami.edu/dcic-portal/) for its good predictive capabilities for the whole
genome expression profile. It has also been demonstrated in [16] that deep
networks can accurately recover the whole genome expression profile using
only L1000 expression information. An additional advantage of using L1000
genes is that LINCS provides efficient and low-cost assays for measuring the
expression of these genes.
Gene expression data is available in multiple formats. High throughput
(HT) sequence counts (i.e., raw counts of gene transcripts) are the most
frequently used measurements for describing expression, and all other data
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representations are derived from these counts. However, since DNA tran-
scripts have different lengths and concentrations, the raw counts may not
accurately reflect the relative expression level. To mitigate this problem, raw
counts are transformed into Fragments Per Kilobase of Transcript per Million





Here, RC(g) and L(g) represent the raw counts of reads covered by gene g
and the length of gene g, respectively, while RCpc denotes the total raw count
of reads mapped to all protein coding genes.
In all our experiments, we use FPKM readings of the 978 Landmark
genes as inputs. The actual FPKM data was retrieved from The Cancer
Genome Atlas (TCGA) project (https://cancergenome.nih.gov/). We
selected five different cancer (sub)types: lower grade glioma (LGG), glioblas-
toma (GBM), lung adenocarcinoma (LUAD), lung squamous cell carcinoma
(LUSC) and stomach adenocarcinoma (STAD). We extracted all available
Landmark gene expression datasets (https://portal.gdc.cancer.gov/, down-
loaded March 2018).
Since most CpG sites are naturally methylated inside a gene, we focus on
methylation measurements of individual CpG sites within promoter regions.
Genes of interest include well-known cancer biomarkers, MGMT, MLH1,
ATM, GATA6, CASP8, KRAS and TP53 (see the Supplementary Material,
Section 1). Information available at TCGA includes methylation microarray
values for 7, 6, 4, 2, 3, 6 and 3 CpG sites in the promoter region of these
genes, respectively. Since genes in different cancer types have nonuniform
methylation levels as measured in terms of coverage of the methylated sites,
the recorded readings only capture the percentage of methylated CpG sites
(bottom, right-hand format in Figure 1.1). We convert these percentages
into binary values by thresholding at 10%, as suggested in multiple prior
works [22]. The output of this preprocessing step is an m-dimensional binary
vector, where m is the number of CpG sites in the promoter region of the
underlying gene.
As one needs to ensure that both methylation and expression data are
available for the same sample, the test data included 511 samples from LGG,
126 from GBM, 511 from LUAD, 500 from LUSC, and 375 from STAD. This
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amounts to a total of 637 samples for brain cancer (LGG and GBM), and
1011 samples for lung cancer (LUAD and LUSC). In all subsequent analyses,
these datasets were split into training and test sets in a 80%-20% proportion.
In summary, we used 978-length positive real-valued vectors containing
the FPKM counts of Landmark genes as inputs of a learner tasked with
predicting binary methylation patterns with m entries, corresponding to our
preselected biomarker genes.
2.2 Mathematical Approaches
There exist many methods that may be used for associating different types of
multiomics data. Among these, the most frequently used approaches include
canonical correlation analysis (CCA) [23], multiclass regression (MR) and
fully connected neural networks (FCNN) [24]. However, these techniques
have limitations that make them unsuitable for the problem at hand, as
described in what follows. Note that to demonstrate the drawbacks of CCA,
MR, and FCNN, we actually applied these methods on the curated datasets
and reported their performance.
2.2.1 Canonical Correlation Analysis
Canonical correlation analysis (CCA) is widely used to infer linear relation-
ships between two correlated random measurements (e.g, random vectors)
X ∈ Rn and Y ∈ Rm. In our setting, n = 978, and each X corresponds to
the gene expression profile of a cancer patient, while m ≤ 7 and each Y cor-
responds to a binary DNA methylation pattern of the same cancer patient.
The CCA objective formally reads as:
(W ′x,W
′







W Ty CY YWy
,
where CXY is the empirical covariance matrix of X and Y computed using all
s ≤ 1011 available samples for each individual cancer type. Then, Wx ∈ Rs,
Wy ∈ Rs. Intuitively, CCA aims to find a subspace such that the projections
Wx and Wy of the random vectors X and Y , respectively, have the largest
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possible correlation. This optimization process can be repeated sequentially
to obtain a sequence of pairs of random vectors (Wx,Wy) that are mutually
uncorrelated, akin to what is standardly done in eigendecomposition prob-
lems.
CCA may be directly applied to our data, but it does not provide a con-
structive means for inferring methylation patterns based on expression; fur-
thermore, it can only identify linear dependencies between two data sample
matrices. In addition, given that we have more features (978 genes) than
samples (less than 600 for each cancer subtype), highly-correlated projections
arise naturally and are easy to identify through the described optimization
process. Table 2.1 illustrates this point for the case of CCA analysis on the
MGMT gene, and all cancer subtypes. As expected, canonical correlation
values in this case exceed 0.94.
Table 2.1: The first three canonical correlation values for the MGMT gene
according to cancer subtype.
LGG GBM BRAIN LUAD LUSC LUNG STAD
1st 0.99 1.00 0.99 0.99 0.99 0.96 0.99
2nd 0.99 1.00 0.98 0.99 0.99 0.96 0.99
3rd 0.99 1.00 0.98 0.99 0.99 0.94 0.99
2.2.2 Multiclass Logistic Regression
A methylation pattern is represented by a binary vector of length m, where
we recall that m denotes the number of CpG sites in the promoter region of
a gene of interest. Hence, a methylation pattern corresponds to one of 2m
possible binary vectors (classes). Since in our case m ≤ 7, multiclass logistic
regression is a natural candidate for prediction.
Let ωy be the weight of the class label y ∈ [0 : 2m − 1]. The posterior
probability of the class label given a particular expression profile X = x may
be written as






Under the assumption that all samples are drawn independently from each
other, the goal is to maximize the product of p(y|x) over all pairs (x, y).
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Multiclass logistic regression is only guaranteed to perform well for lin-
early separable data [24]. Due to the large dimension of gene expression
vectors, it is computationally difficult to determine if the datasets of interest
are linearly separable or not. To address this problem, we first performed
dimensionality reduction via principal component analysis (PCA) and then
visually inspected the data. Figures 2.1 and 2.2 depict the obtained results
for two principle components of training and test samples, for the LGG and
LUNG (e.g., the combination of LUAD and LUSC) cancer subtype(s), re-
spectively. Only results for the GATA6 gene are shown; the results for other
cancer types and genes are available in section 2 of the Supplementary Mate-
rial. It can be observed that the chosen methylation patterns are not linearly
separable. For LGG, we observed two classes of methylation patterns (light
and dark blue points) that exhibit a small degree of separability, whereas for
LUNG, the two patterns are superimposed onto each other. Hence, multiclass
logistic regression is not expected to perform well on most of the data involv-
ing multiple labels (see Table 2.2, and in particular, the values corresponding
to cancer types LGG and LUNG).
Figure 2.1: Visualization of the first two principal components of LGG
cancer data for the GATA6 gene.
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Figure 2.2: Visualization of the first two principal components of LUNG
cancer data for the GATA6 gene.
Figure 2.3: Architecture of a three-layer fully connected neural network.
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2.2.3 Fully Connected Neural Network
FCNNs are a method of choice for many classification tasks [25] as they do
not require data to be linearly separable for practically good performance.
Figure 2.3 depicts the structure of a classic three-layer FCNN. Each neuron
in the network uses a nonlinear activation function on a linear combination
of the outputs from the previous layer. The activation function introduces
nonlinearities into the network model and increases its expressive power com-
pared to linear models such as logistics regression or support vector machines
(SVM) [24]. There are many choices for the nonlinear function, but we re-
strict our attention to rectified linear units (ReLUs) as they have constant
gradients during training and are commonly used in practice.
When the activation function equals the identity function and the loss is
chosen appropriately, the resulting shallow network is equivalent to a linear
model (e.g., a linear model such as logistic regression). Hence, one expects
fully connected neural networks to be more accurate in finding the correct as-
sociation between the gene expression profiles and the methylation patterns.
Nevertheless, fully connected neural networks may fail to take into account
possible correlations between genes, which considerably compromises their
performance (see Table 2.2).
Table 2.2: Accuracy of multiclass regression (MR) and fully connected
neural network (FCNN) methods according to cancer data type, for gene
GATA6.
LGG GBM BRAIN LUAD LUSC LUNG STAD
MR 0.83 0.38 0.79 0.71 0.98 0.70 0.96
FCNN 0.84 0.35 0.82 0.71 0.99 0.85 0.96
2.3 Inception-Based Deep Network E2M
To address the issues present in the previously described methods, we pro-
pose a new method for mining associations between methylation patterns
and Landmark gene expressions, termed E2M. The approach is based on a
novel neural network learning framework centered around so-called inception
neural network learners [17].
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Figure 2.4: Architecture of an inception module.
Inception networks include modules that mitigate certain problems en-
countered in simple fully connected networks (Figure 2.4). One such problem
pertains to capturing long-distance interactions between genes and correla-
tions between their expressions, which can be addressed in part by adding
convolutions. However, since the interaction distance is not known a priori,
it cannot be used to inform the choice of the depth of convolution. Incep-
tion modules therefore include multiple convolutions of different depths at
the same layer. Another component is the filter stack, which aggregates the
outputs of the convolutions and pooling layers, and feeds them to the next
network layer. These features make inception networks more robust and al-
low them to converge faster than traditional convolutional neural networks.
E2M includes two 1D convolution and maxpooling layers that increase
the number of filters and reduce the dimension of the feature space. These
layers are followed by two inception modules of the form shown in Figure 2.4.
This structure is terminated by a fully connected layer that “flattens” the
output (i.e., converts a matrix into a vector via column concatenation) and
a softmax layer that is used to make the predictions. We point out that the
largest contribution to the storage footprint of neural network learners comes
from the fully connected layer that is densely connected. As a result, even
though the E2M structure may appear to have higher description complexity
than a fully connected network, it actually uses fewer parameters than a 3-
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layer fully connected network, and is consequently faster, more compact and
less prone to overfitting.
2.4 Quantized E2M and Gene Expression Values
As the depth of neural networks increases, their storage and running costs
become prohibitively high for many practical applications. While training
a neural network model, it is important to maintain high data precision in
order to propagate accurate gradient information. Nevertheless, it has been
shown that quantizing the weights of an already trained neural network, if
done properly, only slightly degrades its performance and occasionally even
improves it [26, 27]. In addition, since the FPKM gene expression readings
are normalized to convey relative expression differences among genes, it is
unnecessary to force them to be of high precision. Furthermore, original
counts can always be recomputed from their corresponding FASTQ files,
which are standardly stored in a lossless manner. Hence, in our experiments,
we also consider quantizing the input gene expression data.
For network quantization, we identify the largest and smallest weights in
each layer, and bin all other weights according to uniform quantization rules,
with 16−, 8−, or 4−bit level representations. Note that full precision floating
point data in our setting are represented with 64 bits. To perform network
weight quantization, we use a built-in function of TensorFlow that allows for
performing quantized weights multiplication and addition, without mapping
them back to the floating point format. To quantize gene expression values,
we select a cut-off threshold for the top 5% highest-reading genes; readings





In this chapter, we present our findings regarding associations between methy-
lation patterns and Landmark expression profiles for different cancer types
and genes. In the process, we first identify through extensive data analysis
the most suitable inception network parameters, module and layer numbers.
Then, we proceed to compare the performance of the proposed E2M frame-
work to that of multiclass logistic regression and a three-layer fully connected
neural network. We then describe the effects of quantization of network
weights and input expression data under the E2M approach. Our discussion
concludes with an interpretation of the uncovered biological phenomenon.
3.1 E2M Parameter Selection
A detailed description of the structure of the newly proposed E2M learner
can be found in Table 3.1. The reported parameters were chosen using cross-
validation methods on the entirety of the training data described in the
previous section, by splitting it into a 90 : 10 proportion. Subsequently, for
36 sets of parameters, we trained the network on the 90% training set and
tested it on the remaining 10% dataset. The selected parameters were the
best-performing ones under the validation setting.
3.2 Performance Analysis of E2M
We compared the performance of the chosen E2M framework with MRs and
three-layer FCNNs, and summarized the results in Table 3.2. The results
correspond to all chosen cancer types and gene GATA6; the results pertaining
to the remaining selected genes may be found in Section 5 of Supplementary
Material (Tables 3 and 4).
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Table 3.1: Detailed structure of the proposed E2M framework with 128
classes. The entries in column numbers 3− 6 correspond to the number of
parallel convolutions (filters). The last column lists the number of











conv 1 489 × 32 64 0.5k
maxpool 1 244 × 32
conv 2 122 × 64 64 10k
maxpool 2 61 × 64
inception 1 20 ×144 32 32 16 13k
inception 2 6 × 248 64 32 8 28k
fc 1 100 × 1 148k
softmax 128 × 1 13k
Table 3.2: Comparison of accuracies of different prediction methods applied
to gene GATA6 and all considered cancer types. The best results are
highlighted in bold font. Note that the accuracy of random guessing is 0.25,





LGG 0.83 0.84 0.90
GBM 0.38 0.35 0.58
BRAIN 0.79 0.82 0.81
LUAD 0.71 0.71 0.69
LUSC 0.98 0.99 0.99
LUNG 0.70 0.85 0.84
STAD 0.96 0.96 0.96
Average 0.77 0.79 0.82
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As may be observed from the table, at least one of the two nonlinear
network models always outperforms logistics regression for all tested cases.
The reason, as explained in the previous section, is that the data used may
not be linearly separable. Once again, we point out the results for LGG and
LUNG cancers. From Figures 2.1 and 2.2, it is apparent that LGG data
is easier to separate in the principal component space than LUNG data. In
particular, for the LGG dataset, MR and FCNN perform very similarly (0.83
and 0.84, respectively), while E2M offers the best performance (0.90). On the
other hand, for LUNG data, the non-linear models outperform the logistic
regression model by 15%. From the table, we also observe that in most
cases our proposed inception network E2M has higher prediction accuracy
than FCNN. For example, for LGG and GBM, E2M exhibits a 6% and 23%
improvement over FCNN, respectively. Whenever FCNN outperforms E2M,
the difference in performance is only about 1−2%. Hence, E2M offers the best
average performance among all the methods under consideration (additional
results along the same line may be found in section 5 of the Supplementary
Material).
Given that E2M offers the best average performance of all tested methods,
we henceforth restrict our attention to this method only. Table 3.3 provides
the performance results of E2M for all cancer types and all selected genes
(the biological relevance of the bold font and italic values will be described
in Chapter 4).
Table 3.3: Prediction accuracy of E2M for all considered cancer types and
genes. The row RG lists the accuracy of random guessing.
Gene MGMT MLH1 ATM GATA6 CASP8 KRAS TP53
RG (0.008) (0.016) (0.0625) (0.25) (0.125) (0.016) (0.125)
LGG 0.56 0.75 0.99 0.90 0.99 0.84 0.96
GBM 0.31 0.61 0.92 0.58 0.88 0.80 1.00
BRAIN 0.53 0.69 0.98 0.81 0.98 0.84 0.98
LUAD 0.83 0.42 0.73 0.69 0.62 0.38 0.84
LUSC 0.64 0.65 0.94 0.99 0.63 0.92 0.99
LUNG 0.71 0.53 0.85 0.84 0.58 0.68 0.90
STAD 0.65 0.44 0.84 0.96 0.63 0.79 0.95
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3.3 Performance of the Quantized E2M Method
Table 3.4 shows an example of how quantization of network parameters and
input data influences the prediction accuracy of E2M for all considered can-
cer types and genes. We only report on the results obtained using 16-bit
uniform quantization of all network weights and 8-bit uniform quantization
on the expression input data (see section 6 in Supplementary Material for
results with other quantization levels). For ease of data interpretation, the
numbers in parenthesis correspond to the prediction accuracy values without
quantization. As may be observed, there is almost no degradation in the
performance of the quantized E2M method, and in some cases, quantization
even improves the prediction results. The only degradations observed are for
GBM – gene GATA6, LUAD – gene ATM, and LUNG – gene CASP8. An
explanation for this finding is described in Chapter 4.
Table 3.4: Prediction accuracy of E2M with network weights quantized to
16 bits, and expression inputs quantized to 8 bits.










































































































We also remark that for the three cases with compromised performance
under quantization, the predicted patterns are at small Hamming distance
from the correct one. In other cases, like GBM and gene GATA6, the Ham-
ming distance between predicted patterns is at least two, and hence E2M
may be quantized with even fewer bits while preserving prediction accuracy.
In conclusion, aggressive quantization in most cases leads to small predic-
16
tion performance degradation, while providing significant storage savings: in
the example provided, input data is reduced to 1/8 of its size and the quan-





We start with a discussion that highlights the reason behind the variations in
the performance of various prediction methods for different genes and cancer
types. We then proceed to interpret the sources of variation in a biological
context.
The results previously presented in Table 3.3 reveal that the prediction
accuracy of E2M varies widely for fixed genes and different cancer types.
For example, the prediction accuracy for the methylation pattern of gene
GATA6 in LUSC and STAD cancers is 0.99 and 0.96, respectively. On the
other hand, for the same gene, the prediction accuracy for cancer types such
as GBM and LUAD is significantly lower, around 0.6. To gain more insight
into why these variations in accuracy prediction arise, we plot the histograms
for different methylation patterns of gene GATA6 in Figure 4.1. For the
GATA6 we observe only one dominant methylation pattern in LUSC and
STAD. As a consequence, it is unsurprising that the prediction accuracy of
the methylation pattern for cancer types LUSC and STAD is close to one for
all methods tested and presented in Table 3.2.
Interestingly, for the same gene GATA6 we observe 3 and 2 different methy-
lation patterns in GBM and LUAD, respectively. The most likely methyla-
tion pattern for GBM has a frequency of about 40%, and this matches the
performance of the logistic regression and the fully connected network meth-
ods. Indeed, a quick check of the results reveals that the two aforementioned
methods almost always predict the dominant methylation pattern. On the
other hand, E2M is able to capture and predict some of the additional, non-
dominant patterns, which is one of the reasons behind its significant perfor-
mance improvement.
Similar results may be observed in Table 3.3 for other genes and methyla-
tion patterns. The blue and italic entries correspond to cases for which there
is a unique dominant methylation pattern in the data, and hence the predic-
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(a) LUSC and gene GATA6 (b) STAD and gene GATA6
(c) GBM and gene GATA6 (d) LUAD and gene GATA6
Figure 4.1: Histograms of methylation patterns present in the promoter of
gene GATA6 for cancer types (a) LUSC, (b) STAD, (c) GBM, and (d)
LUAD.
tion accuracy of E2M is high. The significantly more interesting results are
listed in red and bold font as they correspond to settings in which there is
more than one dominant methylation pattern, and E2M is able to capture at
least one more pattern than the other investigated methods. The histograms
for all other cancer types and genes considered in the study may be found in
Section 3 of the Supplementary Material.
The previous discussion reveals that for different combinations of genes
and cancer types one either observes a single dominant or multiple methy-
lation patterns (as many as 12, for the case of gene MGMT and all cancers
considered). Let us turn our attention back to Table 3.3. For example, the
promoter regions of gene TP53 and ATM exhibit one dominant methylation
pattern (0, unmethylated) across all considered cancer types, while the ob-
served Landmark gene expression profiles differ significantly. This suggests
that methylation in TP53 and ATM is most often not the cause of charac-
teristic changes in expression values, and that other regulatory phenomena
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and point and copy-number mutations may be at work. On the other hand,
the promoter regions of genes MLH1, MGMT, CASP8 and KRAS exhibit
multiple methylation patterns across all cancer types, with no clear domi-
nant pattern; and, the methylation patterns in MLH1, GATA6 and MGMT
associate strongly with the corresponding Landmark gene expressions.
For a more in-depth explanation of these events, we consider BRAIN cancer
and gene GATA6 as an illustrative example. Figure 4.2 shows the heatmap
of the expression data of the Landmark genes (left column), as well as the
top 15 varying genes (right column), across four types of methylation pat-
terns found in the promoter region of gene GATA6. The horizontal lines in
each plot separate the different methylation patterns, sorted by their deci-
mal representation, and the color of each grid represents the magnitude of
FPKM readings of the corresponding gene. The right column reveals that the
expression levels of genes ALDOC, GAPDH, SPP1, APOE, and HLA-DRA
change jointly in response to different methylation patterns.
Figure 4.2: Heatmap of cancer type BRAIN and gene GATA6.
To test if the interactions among these genes are due to chance, we per-
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formed an enrichment analysis for the selected genes using the pathway
datasets KEGG, Biocarta, GeneSigDB, and Reactome. For each pathway,
we performed a Fisher exact test with a Null hypothesis assuming mutual in-
dependence of the gene variables in the query set. We computed the p-values
after multiple testing correction, and only selected those with a false discovery
rate (FDR) less than 0.05. The pathways related to BRAIN cancer (identified
through rejection of Null) are the KEGG ALZHEIMERS DISEASE (from
KEGG), the REACTOME GLUCOSE METABOLISM, the METABOLISM-
OF CARBOHYDRATES (from Reactome) and the Mouse Brain Joha-nsson
and genes UpRegulatedbyHypoxia (from GeneSigDB). It is known from pre-
viously reported studies that these pathways are indeed involved in the pro-
gression of brain cancer [28, 29, 30, 31].
In summary, our most important biological finding is that patterns of
methylation sites, rather than the global methylation status of a gene (methy-
lated or unmethylated) alone, govern Landmark and global gene expressions.
This observation is strongly supported by the good predictive performance
of E2M on the CASP8 gene for LUAD and STAD, and the MLH1 gene for
STAD. In both cases, at least two patterns which are both deemed globally





We proposed an inception based deep learning framework, termed E2M, capa-
ble of associating specific methylation patterns in gene promoter regions with
Landmark and consequently global gene expression. We tested the proposed
framework on TCGA data including five cancer types, and the promoter
regions of seven genes. Our findings were two-fold. First, we showed that
the proposed E2M framework outperforms multiclass logistics regression and
three-layer fully connected network in prediction accuracy. Furthermore, the
performance of E2M was shown not to be affected by quantization of both
the input data and the weights of the inception network. Second, we found
that methylation of some tumor suppressor genes does not have a detectable
influence on the expression profiles; at the same time, different methylation
patterns in the promoter regions of the same gene can lead to observable
changes in the gene expressions, even when the patterns result in the same
binary methylation status.
As a final remark, we point out that E2M is a general learning framework
that may be successfully applied to other multiomics data association studies
and single cell researches [10].
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The Supplementary Material provides more comprehensive findings for both
the comparative performance of E2M and regarding the biological signifi-
cance of methylation patterns. In particular, we report results for all chosen
genes (MGMT, MLH1, ATM, GATA6, KRAS, CASP8 and TP53) and can-
cer types, including results for MR (multiclass regression), FCNN (fully con-
nected neural network) and E2M, PCA results, histograms of methylation
patterns and expression heatmaps for all datasets. Details may be found in
the file “Supplementary.pdf”.
27
